Reuters logo
BRIEF-Kiadis Pharma says first patient enrolled in ATIR101 phase II clinical trial
October 20, 2015 / 5:43 AM / 2 years ago

BRIEF-Kiadis Pharma says first patient enrolled in ATIR101 phase II clinical trial

Oct 20 (Reuters) - Kiadis Pharma BV :

* Announces enrolment of first patient in its repeat-dosing phase II clinical trial with ATIR101

* Patient was enrolled in Hamilton, Canada within a month of receiving regulatory approval for the study from the Canadian authorities

* Study has now been approved by authorities in Canada, Belgium and the United Kingdom, with approval pending in Germany

Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below